Acute lymphoblastic leukemia. Acute lymphoblastic leukemia, in relapse
Conditions
Interventions
Intervention 1: Intervention group: Group 1 patients receive 0.2% chlorhexidine mouthwash twice a day for 1 month. Intervention 2: Intervention group: group 2 patients receive a combined mouthwash (c
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Years to 18 Years
Inclusion criteria
Inclusion criteria: Patients with ALL undergoing chemotherapy with the same treatment protocol Patients with neutropenia without oral mucositis Hospitalized patients in Shahid Sadoughi hospital
Exclusion criteria
Exclusion criteria: Lack of consent of the patient's parents
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of mucositis. Timepoint: Oral intervention will be carried out for at least 1 month and twice a day, and patients will be clinically examined by a pediatric oncology specialist every week. Method of measurement: Mucositis grading criteria (grade 0 to 4) according to WHO. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain severity. Timepoint: Oral intervention will be carried out for at least 1 month and twice a day, and patients will be clinically examined by a pediatric oncology specialist every week. Method of measurement: Using VAS score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMotahare Taghvaei
Yazd University of Medical Sciences
Outcome results
None listed